De-Novo Belatacept Therapy is Associated with an Increased Risk of Invasive CMV Disease After Kidney Transplantation
De-Novo Belatacept Therapy is Associated with Higher Levels of BK Viremia and Lower Rates of BK Clearance in Kidney Transplantation Patients
Deceased Donor Kidney Transplantation from Donors with Acute Kidney Injury: Realities and Costs
Deceased Donor Procurement Biopsy Practices, Interpretation, and Histology-Based Decision Making: A Survey of US Transplant Centers
Deceased Donor Vein Extension Grafts for Right Living-Donor Kidney Transplantation
Deep-Learning Based Pathological Assessment of Frozen Procurement Kidney Biopsies
Defining New Arterial and Arteriolar Lesions Accompanying Transplant Glomerulopathy: Potential Additions to the Histologic Assessment of ABMR
Defining the Characteristics and Graft Outcomes of Kidney Transplant Recipients with Pre-Transplant Elevated Plasma Oxalate Levels
Delayed Graft Function in Living Donor Kidney Transplantation: Risk Factors and Outcomes
Desensitization Protocol Consisting of High-Dose Intravenous Immunoglobulin, Plasmapheresis, and Rituximab in Highly Sensitized Kidney Transplant Recipients
- « Previous Page
- 1
- …
- 10
- 11
- 12
- 13
- 14
- …
- 54
- Next Page »